Placebo
Showing 9976 - 10000 of >10,000
Sexually Transmitted Diseases Trial in Antwerp (Mouthwash with LCM, Mouthwash with )
Terminated
- Sexually Transmitted Diseases
- Mouthwash with LCM
- Mouthwash with placebo
-
Antwerp, BelgiumInstitute of Tropical Medicine
Apr 12, 2021
Crohn Disease, Colitis, Ulcerative Trial (TEV-48574, Placebo)
Not yet recruiting
- Crohn Disease
- Colitis, Ulcerative
- TEV-48574
- Placebo
- (no location specified)
Aug 11, 2022
COPD Trial in Lodz (Beclometasone/formoterol/glycopyrrolate, Placebo)
Completed
- COPD
-
Lodz, Ul. Kopcińskiego 22, PolandMedical University in Lodz
Oct 28, 2021
Pulmonary Disease, Chronic Obstructive Trial in Harrow (GSK961081, GSK961081 matching , Propranolol)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
- +3 more
-
Harrow, Middlesex, United KingdomGSK Investigational Site
Sep 28, 2021
Postoperative Atrial Fibrillation Trial (Atorvastatin 80mg, Placebo)
Recruiting
- Postoperative Atrial Fibrillation
- Atorvastatin 80mg
- Placebo
-
Odense, DenmarkOdense University Hospital
Sep 30, 2022
Herpes Zoster Trial in Xinxiang (Low dose Recombinant Herpes Zoster Vaccine (CHO cells), High dose Recombinant Herpes Zoster
Not yet recruiting
- Herpes Zoster
- Low dose Recombinant Herpes Zoster Vaccine (CHO cells)
- +3 more
-
Xinxiang, Henan, ChinaYanjin Center for Disease Control and Prevention
May 4, 2023
Erythropoietic Protoporphyria, X-linked Protoporphyria Trial in Boston, Winston-Salem, Galveston (Cimetidine, Placebo)
Recruiting
- Erythropoietic Protoporphyria
- X-linked Protoporphyria
- Cimetidine
- Placebo
-
Boston, Massachusetts
- +2 more
Aug 10, 2022
Post Traumatic Stress Disorder Trial in Austin (CBD Isolate, CBD Broad Spectrum, Placebo oil)
Recruiting
- Post Traumatic Stress Disorder
- CBD Isolate
- +2 more
-
Austin, TexasLaboratory for the Study of Anxiety Disorders, University of Tex
Jul 27, 2021
Mild Cognitive Impairment (MCI), Parkinson Disease (PD) Trial (CST-2032, matching for CST-2032, CST-107)
Withdrawn
- Mild Cognitive Impairment (MCI)
- Parkinson Disease (PD)
- CST-2032, matching placebo for CST-2032, CST-107
- (no location specified)
Oct 22, 2021
Functional Dyspepsia Trial in Kansas City (Ketotifen, Placebo)
Recruiting
- Functional Dyspepsia
- Ketotifen
- Placebo
-
Kansas City, MissouriThe Children's Mercy Hospital
Oct 4, 2021
Characteristics That Modify the Response to Cholecalciferol Treatment Trial in United States (Vitamin D3, Placebo)
Completed
- Characteristics That Modify the Response to Cholecalciferol Treatment
- Vitamin D3
- Placebo
-
Los Angeles, California
- +4 more
May 14, 2022
Sedation Trial in Cluj-Napoca (Placebo, Lidocaine)
Recruiting
- Sedation
- Placebo
- Lidocaine
-
Cluj-Napoca, Cluj, RomaniaRegional Institute of Gastroenterology and Hepatology "Prof.dr.O
Mar 10, 2022
Nutrition Status, Nutritional Requirements, Sports Nutritional Sciences Trial (Nature Made Vitamin D3 5,000 IU, 125mcg, Placebo)
Not yet recruiting
- Nutrition Status
- +2 more
- Nature Made Vitamin D3 5,000 IU, 125mcg
- Placebo
- (no location specified)
Aug 8, 2022
Cystic Fibrosis Trial in Minneapolis, Saint Paul (novolog insulin, levemir insulin, )
Completed
- Cystic Fibrosis
- novolog insulin
- +2 more
-
Minneapolis, Minnesota
- +1 more
Aug 8, 2022
Heart Failure Trial in Thiruvananthapuram, Delhi, Ludhiana (AirOk Air Purifier, Placebo Air Filter)
Not yet recruiting
- Heart Failure
- AirOk Air Purifier
- Placebo Air Filter
-
Thiruvananthapuram, Kerala, India
- +2 more
Aug 8, 2022
Endothelial Dysfunction Trial in Nashville (Galantamine, Placebo)
Recruiting
- Endothelial Dysfunction
- Galantamine
- Placebo
-
Nashville, TennesseeChaney Johnson
Dec 22, 2021
Tranexamic Acid, Burns, Surgery Trial in Ars-Laquenexy, Lyon, Marseille (Tranexamic Acid, Placebo)
Active, not recruiting
- Tranexamic Acid
- +3 more
- Tranexamic Acid
- Placebo
-
Ars-Laquenexy, France
- +3 more
Feb 8, 2022
Dysautonomia, Familial, Baroreflex Failure Syndrome Trial in New York (Carbidopa Low-Dose, Placebo, Carbidopa High-Dose)
Completed
- Dysautonomia, Familial
- Baroreflex Failure Syndrome
- Carbidopa Low-Dose
- +2 more
-
New York, New York
- +1 more
Jan 13, 2022
Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)
Recruiting
- Indolent Systemic Mastocytosis
- Monoclonal Mast Cell Activation Syndrome
- BLU-263
- Placebo
-
Palo Alto, California
- +33 more
Jul 27, 2022